We had a pt. receive a chemo which they should not have due to their renal function. Our hospital pharmacy also is responsible for the infusion room patients as we do not have a separate infusion center pharmacy. We routinely verify plts and ANC prior to dispensing chemo and crcl for Carboplatin. I would like to expand our lab monitoring to prevent an error of this sort again.
Would anyone be willing to share which labs are routinely monitored by pharmacy prior to dispensing ?

Does anyone have any useful resources to help guide practices when warming IV solutions. Specifically looking for standards or literature to help with determining a BUD. thanks!

Hello All
We are assessing our utilization of Multi-Dose Vials for chemotherapy IV compounding in a USP800 fully-compliant hazardous IV cleanroom. We would like to better understand specific practices around the use of MDVs if using the same vial on more than one patient. What has been your risk assessment.

Questions:
(1) Do you use MDVs for chemotherapy compounding?

Hello,

For anyone who has cameras in their medication rooms...how long do you retain the video footage for? Is there a standard for this type of thing that anyone knows of?

Thank you,
Lauren

I am hoping someone out there has had an epiphany on how to handle "STAT" drugs that are straight draws, like fosphenytoin and oxytocin, with USP 800 regulations. If you are allowing the nurse to draw them up, how are you documenting that in your Assessment of Risk? If you are having pharmacy draw them up, how are you communicating that with OB, Neuro, ED, etc?

Over half of our 13 hospitals have non-24 hour pharmacies. We are trying to figure out how to have a consistent process in all hospitals at all times...which we realize is a tall order.

Good Morning All! We prepare certain aerosols in Pharmacy for nebulization. Currently, we dispense these agents from Pharmacy in syringes. I would like to move away from this practice. Has anyone identified an alternative/unique dispensing device for this purpose? Thanks in advance!

Our organization has recently been reviewing override data from our Alaris Guardrails and adjusting max/min for medications that are causing a high percentage of overrides. Propofol has emerged as an outlier for our organization in our ICU. Our current soft min is set at 50 mcg/kg/min but a large portion of our patients at certain hospitals are averaging 100-150 mcg/kg/min. I am wondering what other organizations have done with regard to limits on this medication since there are recommendations to try to maintain infusion rates below 67 mcg/kg/min to prevent PRIS.

Hi All
i am reviewing our alaris guardrails for heparin infusions and curious as to how other institutions are setting their guardrails mins/max's. we currently have 2 options - regular dose (below 2,500 units/hr and high dose (> 2,500 units/hr) but this seems to be causing a lot of unnecessary alerts. thinking of combining back to 1 option and trying to figure out the best soft min; soft max and hard max settings. what settings do you use at your institution? any other tips/tricks you are using to mitigate transcription issues would be much appreciated!

Hi,

Does anyone have any strategies for enhancing the safety of storage of many vaccines in a clinic setting? Although not on the LASA list, many do have similar names and appearances and with up to 15 vaccines used at one site we want to minimize the risk of a mix-up.

Thank you.

We are undertaking an overhaul of the which medications/processes require an independent double check / witness within the EMR. It is widely publicized that IDCs are commonly overused and misused. This in-turn degrades the utility of IDCs put in the correct place on correct meds/processes.

The goal would be to develop guidelines that could be used to determine if a med/process qualifies for an IDC, then it would go to the Medication Safety Team to make final determination along with other recommendations.